Back to Awarded Treatment Trials
Awarded Trial: 02I-007
Grant ID
02I-007
Illness
Schizophrenia
Primary Drug/Intervention
Tianma (gastrodia elata B1.)
Primary Dosage
800 mg/tid
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Ma
Sample Size
200
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
PANSS, BPRS
Results
A significantly greater percentage of patients receiving Tianma were classified as "clinical cures". Patients receiving Tianma also demonstrated a significant reduction in the PANSS total score reduction ratio, and the PANSS positive score reduction ratio.
Publication
N/A
Link
N/A
PI Name
Ping Ma
Degree
MD
Center
Immunology Laboratory
Institution
Chengdu University
Address
#37, 12th Bridge Road
City or Town
Chengdu
State or Province
Sichuan
Zip or Postal Code
610075
Country
China
Email Address
mmpp@vip.sina.com